CAS 893772-67-3

Formule : C12H7F3N4O2

InChI : InChI=1S/C12H7F3N4O2/c1-19-7-3-2-5(12(13,14)15)4-6(7)16-8-9(19)17-11(21)18-10(8)20/h2-4H,1H3,(H,18,20,21)

Code InChI : KCDITQBGZLRTBX-UHFFFAOYSA-N

SMILES : CN1C2=C(C=C(C=C2)C(F)(F)F)N=C3C1=NC(=O)NC3=O

10-Methyl-7-(trifluoromethyl)benzo[g]pteridine-2,4(3h,10h)-dione

CAS : 893772-67-3

10-Methyl-7-(trifluoromethyl)benzo[g]pteridine-2,4(3h,10h)-dione

Formule : C₁₂H₇F₃N₄O₂

Degré de pureté : 97%

Masse moléculaire : 296.2

Ref: 54-PC1027945

10-methyl-7-(trifluoromethyl)benzo[g]pteridine-2,4(3H,10H)-dione

CAS : 893772-67-3

Formule : C₁₂H₇F₃N₄O₂

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 296.2048

Ref: IN-DA00JH64

PLK1-IN-9

CAS : 893772-67-3

PLK1-IN-9 (Compound M2), a polo-like kinase 1 (PLK1) inhibitor, targets the PLK proteins modified with peptides 1010pT, cdc25c, and PBIP, exhibiting IC₅₀ values of 1.6, 0.8, and 1.4 μM, respectively. This compound effectively inhibits the proliferation of various cancer cell lines including HeLa, HL60, SNU387/499, and HepG2, demonstrating cytotoxic effects and inducing apoptosis. Additionally, PLK1-IN-9 has been shown to suppress tumor growth in a HepG2 xenograft mouse model.

Formule : C₁₂H₇F₃N₄O₂

Masse moléculaire : 296.2048

Ref: TM-T87975

10-Methyl-7-(trifluoromethyl)benzo[g]pteridine-2,4(3H,10H)-dione

Produit contrôlé

CAS : 893772-67-3

Formule : C₁₂H₇F₃N₄O₂

Couleur et forme : Neat

Masse moléculaire : 296.205

Ref: TR-M130640